MCID: BLS002
MIFTS: 42

Blastomycosis malady

Categories: Rare diseases, Infectious diseases, Skin diseases

Aliases & Classifications for Blastomycosis

About this section

Aliases & Descriptions for Blastomycosis:

Name: Blastomycosis 10 45 12 36 2 65
North American Blastomycosis 10 45
Gilchrist's Disease 10 45
Infection by Blastomyces Dermatitidis 10
Blastomyces Dermatitidis Infection 10
 
Blastomycosis, Unspecified 10
Blastomycotic Infection 10
Blastomycosis Nos 10
Gilchrist Disease 65
Chicago Disease 10

Classifications:



External Ids:

Disease Ontology10 DOID:12663
ICD1027 B40, B40.9
ICD9CM29 116, 116.0
MeSH36 D001759
UMLS65 C0005716, C0005717

Summaries for Blastomycosis

About this section
CDC:2 Blastomycosis is an infection caused by a fungus called Blastomyces. The fungus lives in the environment, particularly in moist soil and in decomposing matter such as wood and leaves. Blastomyces mainly lives in areas of the United States and Canada surrounding the Ohio and Mississippi River valleys and the Great Lakes. People can get blastomycosis after breathing in the microscopic fungal spores from the air. Although most people who breathe in the spores don’t get sick, some of those who do may have flu-like symptoms, and the infection can sometimes become serious if it is not treated.

MalaCards based summary: Blastomycosis, also known as north american blastomycosis, is related to atopic dermatitis and lobomycosis, and has symptoms including skin lesions, lung lesions and pleural thickening. An important gene associated with Blastomycosis is GC (Group-Specific Component (Vitamin D Binding Protein)). The drugs itraconazole and fluconazole have been mentioned in the context of this disorder. Affiliated tissues include skin, lung and bone, and related mouse phenotypes are endocrine/exocrine gland and homeostasis/metabolism.

Disease Ontology:10 A primary systemic mycosis that results in a systemic fungal infection, has material basis in Blastomyces dermatitidis, transmitted by airborne spores and has symptom skin lesions, has symptom lung lesions and has symptom pleural thickening.

NIH Rare Diseases:45 Blastomycosis is a rare infection that may develop when people inhale a fungus called blastomyces dermatitidis, a fungus that is found in moist soil, particularly where there is rotting vegetation. the fungus enters the body through the lungs, infecting them. the fungus then spreads to other areas of the body. the infection may affect the skin, bones and joints, and other areas. the disease usually affects people with weakened immune systems, such as those with hiv or who have had an organ transplant. last updated: 12/9/2011

Wikipedia:68 Blastomycosis (also known as \"North American blastomycosis\", \"Blastomycetic dermatitis\", and... more...

Related Diseases for Blastomycosis

About this section

Graphical network of the top 20 diseases related to Blastomycosis:



Diseases related to blastomycosis

Symptoms for Blastomycosis

About this section

Symptoms:

 10
  • skin lesions
  • lung lesions
  • pleural thickening

Drugs & Therapeutics for Blastomycosis

About this section

Drugs for Blastomycosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 23)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Amphotericin Bapproved, investigationalPhase 4, Phase 31171397-89-314956, 5280965
Synonyms:
12633-72-6
1397-89-3
30782-62-8
5-18-10-00525 (Beilstein Handbook Reference)
54482-28-9
8055-20-7
AB00513832
ABLC
AC1L1CN2
AC1L24V6
AC1L70KF
AC1L73U6
AC1NQXTD
AC1NTQ32
AC1NUQG4
AC1NY9JC
AC1O7GCZ
AC1O8FQV
AC1O8PFK
AI3-26528
AMPH-B
AMPH-b
Abelcet
Abelecet
AmBisome (TN)
Ambap1397-89-3
Ambisome
Amfotericina B
Amfotericina B [INN-Spanish]
Ampho-Moronal
Amphocin
Amphomoronal
Amphortericin B
Amphotec
Amphotec (TN)
Amphotericin
Amphotericin .BETA.
Amphotericin B
Amphotericin B (JP15/USP/INN)
Amphotericin B Cholesterol Dispersion
Amphotericin B Cholesteryl Sulfate Complex
Amphotericin B Colloidal Dispersion
Amphotericin B [USAN:INN:JAN]
Amphotericin B, Lipid-based
Amphotericin B, Streptomyces sp.
Amphotericin-B
Amphotericine B
Amphotericine B [INN-French]
Amphotericinum
Amphotericinum B
Amphotericinum B [INN-Latin]
Amphotherizin
Amphotherizin [German]
Amphotéricine B
Amphozone
BIDD:GT0351
BPBio1_000374
BRN 0078342
BSPBio_000340
C-AmB
C06573
C47H73NO17
CCRIS 5963
CHEBI:2682
CHEMBL1200646
CHEMBL267345
CID10533925
CID10629638
CID10677275
CID14956
 
CID1972
CID352546
CID354192
CID5280965
CID5386092
CID5458486
CID5771695
CID6604295
CID6708817
CID6713692
CID9919339
D00203
DB00681
DivK1c_007045
EINECS 215-742-2
Fungilin
Fungisome
Fungisone
Fungizone
Fungizone (TN)
HMS1569A22
HSDB 3008
HSDB 3008 IAB
Halizon
I06-0257
KBio1_001989
KBio2_000551
KBio2_003119
KBio2_005687
KBioGR_002298
KBioSS_000551
LMPK06000002
LNS-AmB
LS-187721
LS-93
Liposomal Amphotericin B
Liposomal amphotericin b
MLS002702966
MolPort-006-392-260
Mysteclin-F
NCGC00014913
NCGC00090808-01
NCGC00098014-01
NCGC00179595-01
NCI527017
NCI60_004288
NCIStruc1_001042
NCIStruc2_000920
NKTR-024
NS 718
NSC 527017
NSC-527017
NSC527017
Prestwick0_000410
Prestwick1_000410
Prestwick2_000410
Prestwick3_000410
Prestwick_721
SMP1_000302
SMR001566780
SPBio_000715
SPBio_002279
ST50999656
SinuNase
SpecPlus_000949
Spectrum2_000818
Spectrum4_001779
Spectrum_000111
UNII-7XU7A7DROE
amophotericin B
amphotericin B liposomal
amphotericin b
2
Miconazoleapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 1, Phase 0302622916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
Desenex
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Makesense
Micantin (nitrate)
Micatin
 
Miconasil Nitrate
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Oravig
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
Rash Relief Antifungal
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
3
Voriconazoleapproved, investigationalPhase 4124137234-62-971616
Synonyms:
(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol
(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
(AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(R-(R*,S*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(alphaR,betaS)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
137234-62-9
173967-54-9
AC-823
AC1L2GHR
AC1Q4O6I
AKOS005145705
C07622
C102790
CHEBI:10023
CHEMBL638
CID71616
CPD000466350
D00578
DB00582
DRG-0301
FT-0082604
HMS2051N09
LS-181799
 
MLS000759464
MLS001424082
MolPort-003-850-863
Pfizer brand of voriconazole
S1442_Selleck
SAM001246664
SMR000466350
TL8000858
UK 109,496
UK 109496
UK-109,496
UK-109496
UNII-JFU09I87TR
VCZ
VRC
Vfend
Vfend (TN)
Vfend, Voriconazole
Voriconazol
Voriconazole
Voriconazole (JAN/USAN/INN)
Voriconazole [USAN:INN:BAN]
Voriconazole in combination with MGCD290
Voriconazolum
ZINC00014864
voriconazole
4
deoxycholic acidapprovedPhase 43983-44-37000965, 222528
Synonyms:
5b-Cholanic acid-3a,12a-diol
5b-Deoxycholate
5b-Deoxycholic acid
7-Deoxycholate
7-Deoxycholic acid
Cholerebic
 
Cholorebic
Degalol
Deoxy-Cholate
Deoxy-Cholic acid
Deoxycholatate
Deoxycholate
Deoxycholatic acid
Deoxycholic acid
5Hormone AntagonistsPhase 4, Phase 3, Phase 2, Phase 1, Phase 010002
6Liposomal amphotericin BPhase 4, Phase 3117
7Cytochrome P-450 Enzyme InhibitorsPhase 4, Phase 3, Phase 2, Phase 1, Phase 03036
8Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 2, Phase 1, Phase 09988
9HormonesPhase 4, Phase 3, Phase 2, Phase 1, Phase 011748
10Antifungal AgentsPhase 4, Phase 3, Phase 2, Phase 1, Phase 03015
11Anti-Bacterial AgentsPhase 4, Phase 39140
12Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 1, Phase 017220
13Antiparasitic AgentsPhase 4, Phase 31854
14Antiprotozoal AgentsPhase 4, Phase 31730
15Cytochrome P-450 CYP3A InhibitorsPhase 4, Phase 3, Phase 1, Phase 2, Phase 01421
16Amphotericin B, deoxycholate drug combinationPhase 415
17
Itraconazoleapproved, investigationalPhase 3, Phase 1, Phase 2, Phase 013484625-61-655283
Synonyms:
(+-)-1-sec-Butyl-4-(p-(4-(p-(((2R*,4S*)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)phenyl)-delta(sup 2)-1,2,4-triazolin-5-one
(+/-)-1-[( R *)- sec -butyl]-4-[ p -[4-[ p -[[(2 R *,4 S *)-2-(2,4-dichlorophenyl)-2-(1 H -1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-(DELTA) 2 1,2,4-triazolin-5-one mixture with (+/-)-1-[( R *)- sec -butyl]-4-[ p -[4- [ p -[[(2 S *,4 R *)-2-(2,4-dichlorophenyl)-2-(1 H -1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl] phenyl]-(DELTA) 2 -1,2,4-triazolin-5-one
(1)-cis-4-(4-(4-(4-((2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-2,4-dihydro-2-sec-butyl-3H-1,2,4-triazol-3-one
2-(butan-2-yl)-4-{4-[4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one
2-butan-2-yl-4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one
2-butan-2-yl-4-[4-[4-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one
2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one
3H-1,2,4-Triazol-3-one, 4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-pipera-zinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl)
4-(4-{4-[4-({[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl}oxy)phenyl]piperazin-1-yl}phenyl)-2-(1-methylpropyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
84604-65-9
84625-61-6
AC-542
AC1L1GQ5
AC1L1IRU
AC1OCEL7
AC1Q6EZ3
AKOS000280875
Ambap84625-61-6
BIDD:GT0796
BRN 6042047
C35H38Cl2N8O4
CHEBI:6076
CHEMBL22587
CHEMBL882
CID3793
CID55283
CID6917738
CID9961741
CPD000058959
Canadiol
D00350
DB01167
EINECS 283-347-2
FT-0082511
HMS2051K14
HMS2090M20
Hyphanox
I01-1043
I0732
ITC
ITCZ
ITZ
Intraconazole
 
Itraconazol
Itraconazol [Spanish]
Itraconazole
Itraconazole & Bovine Lactoferrin
Itraconazole & Nyotran
Itraconazole & Nyotran(Liposomal Nystatin)
Itraconazole (JAN/USAN)
Itraconazole [USAN:BAN:INN:JAN]
Itraconazole oral solution
Itraconazolum
Itraconazolum [Latin]
Itrizole
Itrizole (TN)
Itrizole (tn)
LS-1843
MLS000028582
MLS000759472
MLS000863291
MLS001148245
MolPort-000-883-864
MolPort-003-848-295
NCGC00089812-03
Onmel
Oriconazole
Oriconazole, R51211, Sporanox
Orungal
Prokanazol
R 51211
R-51211
S2476_Selleck
SAM001246679
SMR000058959
Sempera
Spherazole
Sporal
Sporanos
Sporanox
Sporanox (TN)
Sporanox (tn)
Sporonox
TL8005525
Triasporn
UNII-304NUG5GF4
cis-Itraconazole
itraconazole
18Antibiotics, AntitubercularPhase 35971
19Pharmaceutical SolutionsPhase 3, Phase 07004
20HydroxyitraconazolePhase 3, Phase 1, Phase 2, Phase 0134
21
FluconazoleapprovedPhase 217186386-73-43365
Synonyms:
2,4-Difluoro-alpha,alpha-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol
2,4-difluoro-,1-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol
2-(2,4-DIFLUOROPHENYL)-1,3-DI(1H-1,2,4-TRIAZOL-1-YL)PROPAN-2-OL
2-(2,4-DIFLUOROPHENYL)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol
2-(2,4-Difluoro-phenyl)-1,3-bis-[1,2,4]triazol-1-yl-propan-2-ol
2-(2,4-Difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)-2-propanol
2-(2,4-Difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol
2-(2,4-Difluorophenyl)-1,3-di-1H-1,2,4-triazol-1-ylpropan-2-ol
2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol
86386-73-4
AC-428
AC1L1FRQ
AC1Q77FV
AKOS000280854
AbZ Brand of Fluconazole
Afungil
Alflucoz
Aliud Brand of Fluconazole
Alpharma Brand of Fluconazole
Apo Fluconazole
Apo-Fluconazole
Apotex Brand of Fluconazole
Armstrong Brand of Fluconazole
BIDD:GT0799
BRD-K05977355-001-02-6
BSPBio_003504
Baten
Beagyne
Bio-0041
Biocanol
Biozole
Biozolene
C13H12F2N6O
CCRIS 7211
CHEBI:46081
CHEMBL106
CID3365
CPD000471882
Canesoral
Canzol
Chemia Brand of Fluconazole
Cryptal
D00322
D015725
DB00196
DIFLUCAN IN DEXTROSE 5% IN PLASTIC CONTAINER
DIFLUCAN IN SODIUM CHLORIDE 0.9%
DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
DRG-0005
Diflazon
Diflucan
Diflucan (TN)
Diflucan, Trican, Alfumet, Fluconazole
Dimycon
DivK1c_001030
Effik Brand of Fluconazole
Elazor
F0677
F8929_SIGMA
FCZ
FLCZ
Fluc Hexal
Flucazol
FlucoLich
Flucobeta
Fluconazol
Fluconazol AL
Fluconazol AbZ
Fluconazol Isis
Fluconazol Stada
Fluconazol [Spanish]
Fluconazol ratiopharm
Fluconazol von ct
Fluconazol-Isis
Fluconazol-ratiopharm
Fluconazole
Fluconazole & Bovine Lactoferrin
Fluconazole & Human recombinant granulocyte colony stimulating factor
Fluconazole & MC-510,011
Fluconazole & hGCSF
Fluconazole (JAN/USAN/INN)
Fluconazole [USAN:INN:BAN:JAN]
Fluconazole in combination with MGCD290
Fluconazole in dextrose 5% in plastic container
Fluconazole in sodium chloride 0.9%
Fluconazole in sodium chloride 0.9% in plastic container
Fluconazolum
Fluconazolum [Latin]
Flucostat
 
Flucytosine & Nyotran
Flucytosine & Nyotran(Liposomal Nystatin)
Flukezol
Flunazul
Flunizol
Fluzone
Forcan
Fuconal
Fungata
GL663142 & Fluconazole
HMS1922O10
HMS2090I20
HMS2093M21
HMS503M21
HSDB 7420
Hexal Brand of Fluconazole
I06-0069
IDI1_001030
KBio1_001030
KBio2_002134
KBio2_004702
KBio2_007270
KBio3_003009
KBioGR_000360
KBioSS_002134
KS-1059
LS-1858
Lavisa
Lesvi Brand of Fluconazole
Lichtenstein Brand of Fluconazole
Loitin
MLS001066394
MLS001165780
MLS001195645
MLS001304713
MLS001306492
Mack Brand of Fluconazole
MolPort-000-883-859
MolPort-002-885-825
Monicure
Mutum
NCGC00095089-01
NCGC00095089-02
NCGC00095089-04
NCGC00095089-05
NINDS_001030
Neofomiral
Oxifugol
Oxifungol
Pfizer Brand of Fluconazole
Pfleger Brand of Fluconazole
Pritenzol
S1331_Selleck
SAM002589905
SAT Brand of Fluconazole
SMR000471882
SPBio_001613
SPECTRUM1503975
STK619301
Silanes Brand of Fluconazole
Solacap
Spectrum2_001607
Spectrum3_001912
Spectrum4_000090
Spectrum5_001277
Spectrum_001654
Stada Brand of Fluconazole
Syscan
TL8005609
TPF
Triflucan
UK 49858
UK-49858
UK49858
UNII-8VZV102JFY
Vita Brand of Fluconazole
XMP.284 & Fluconazole
XMP.366 & Fluconazole
XMP.391 & Fluconazole
ZINC00004009
Zemyc
Zoltec
Zonal
betapharm Brand of Fluconazole
ct Arzneimittel Brand of Fluconazole
ct-Arzneimittel Brand of Fluconazole
fluconazole
nchembio.100-comp3
nchembio.65-comp15
ratiopharm Brand of Fluconazole
22Cytochrome P-450 CYP2C9 InhibitorsPhase 2497
23PetrolatumPhase 084

Interventional clinical trials:

idNameStatusNCT IDPhase
1Amphotericin-B and Voriconazole for Pulmonary BlastomycosisRecruitingNCT02283905Phase 4
2A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or HistoplasmosisCompletedNCT00002159Phase 3
3A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal InfectionCompletedNCT00784368Phase 3
4Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and SporotrichosisCompletedNCT00004808Phase 2
5Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and SporotrichosisCompletedNCT00004811Phase 1, Phase 2
6Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With Blastomycosis Dermatitidis InfectionCompletedNCT00001702
7Topical Itraconazole in the Treatment of Basal Cell CarcinomaRecruitingNCT02120677Phase 0

Search NIH Clinical Center for Blastomycosis

Inferred drug relations via UMLS65/NDF-RT43:


Cochrane evidence based reviews: blastomycosis

Genetic Tests for Blastomycosis

About this section

Anatomical Context for Blastomycosis

About this section

MalaCards organs/tissues related to Blastomycosis:

33
Skin, Lung, Bone, Liver, Thyroid, Endothelial, Breast

Animal Models for Blastomycosis or affiliated genes

About this section

MGI Mouse Phenotypes related to Blastomycosis:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053798.2CD4, GATA2, GC, KCNB1
2MP:00053767.6CD4, GATA2, GC, HSD11B2, KCNB1

Publications for Blastomycosis

About this section

Articles related to Blastomycosis:

(show top 50)    (show all 548)
idTitleAuthorsYear
1
SDHB-Deficient Cancers: The Role of Mutations That Impair Iron Sulfur Cluster Delivery. (26719882)
2016
2
Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients. (26134500)
2015
3
Zinc lozenges and vitamin C for the common cold are not examples of placebo effect in action. (26071891)
2015
4
Estimation of serum lipids in patients with Oral Submucous Fibrosis in India. (25136423)
2014
5
The relationship between symptom severity, stigma, illness intrusiveness and depression in Mal de Debarquement Syndrome. (25331814)
2014
6
Pediatric thrombophilia. (24237981)
2013
7
Orbital compartment syndrome following extracorporeal support. (23898881)
2013
8
Characteristics and prognostic factors for head and neck non-Hodgkin's lymphoma in Chinese patients. (23738972)
2013
9
Von hippel-lindau syndrome: diagnosis and management of hemangioblastoma and pheochromocytoma. (23781388)
2013
10
Percentage of the population at high risk of osteoporotic fracture in South Korea: analysis of the 2010 Fifth Korean National Health and Nutrition Examination survey data. (24345885)
2013
11
Asymmetric time-dependent activation of right central amygdala neurones in rats with peripheral neuropathy and pregabalin modulation. (22861166)
2012
12
Positional occlusion of the vertebral artery in a case of rheumatoid atlantoaxial subluxation presenting with multiple cerebral and cerebellar infarction. (22006121)
2012
13
MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs. (22117195)
2012
14
Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study. (22204993)
2012
15
Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review. (20399983)
2010
16
AGC1 deficiency associated with global cerebral hypomyelination. (19641205)
2009
17
Renal collecting duct carcinoma in a dog. (18587095)
2008
18
Novel drugs targeting hypertension: renin inhibitors. (17703126)
2007
19
Mild hydronephrosis in newborns and infants: can ultrasound predict the presence of vesicoureteral reflux. (16967282)
2007
20
ZPR1 is essential for survival and is required for localization of the survival motor neurons (SMN) protein to Cajal bodies. (15767679)
2005
21
Tyrosine phosphorylation of phospholipase D1 by v-Src does not per se result in activation. (15722193)
2005
22
R643G polymorphism in PECAM-1 influences transendothelial migration of monocytes and is associated with progression of CHD and CHD events. (15488875)
2004
23
Legg-Calve-Perthes disease. Part I: Classification of radiographs with use of the modified lateral pillar and Stulberg classifications. (15466719)
2004
24
Interleukin-2 given to asymptomatic HIV-infected individuals leads to an exaggerated response of the pituitary gland to the action of CRH. (12807511)
2003
25
Characterization of the c-Myb-responsive region and regulation of the human type I collagen alpha 2 chain gene by c-Myb. (12424255)
2003
26
Distal motor latency and residual latency as sensitive markers of anti-MAG polyneuropathy. (12928916)
2003
27
Deoxycholic acid causes DNA damage in colonic cells with subsequent induction of caspases, COX-2 promoter activity and the transcription factors NF-kB and AP-1. (12016158)
2002
28
Experiences in the treatment of patients with tinnitus and/or hyperacusis using the habituation method. (11318464)
2001
29
A novel deletion (c663delC) at exon 5 of the proteolipid protein gene in Pelizaeus-Merzbacher disease. (11139261)
2001
30
The role of protein composition in specifying nuclear inclusion formation in polyglutamine disease. (11572863)
2001
31
A case of adolescent body dysmorphic disorder treated with fluvoxamine. (11322739)
2001
32
Characterization of human prostate mast cells and their increase in periprostatic vein thrombosis. (11447759)
2001
33
Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis. (11549587)
2001
34
Effects of cycloheximide and aminophylline on 5-methoxytryptophol and melatonin contents in the chick pineal gland. (11078632)
2000
35
Identification of a series of transforming growth factor beta-responsive genes by retrovirus-mediated gene trap screening. (10757810)
2000
36
Heterodimeric tacrine-based acetylcholinesterase inhibitors: investigating ligand-peripheral site interactions. (10514292)
1999
37
Characterisation of transcript initiation sites in ribosome-deficient barley plastids. (9484490)
1998
38
The clinical significance of p21(WAF1/CIP-1) and p53 expression in pancreatic adenocarcinoma. (9241070)
1997
39
The ileocecal reservoir for rectal replacement in complicated radiation proctitis. (8873525)
1996
40
Ras activity is required for phenylephrine-induced activation of mitogen-activated protein kinase in cardiac muscle cells. (7802678)
1994
41
A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. (7690989)
1993
42
Murine fumarylacetoacetate hydrolase (Fah) gene is disrupted by a neonatally lethal albino deletion that defines the hepatocyte-specific developmental regulation 1 (hsdr-1) locus. (1741389)
1992
43
Identification of p70 and p80 associations with class II MHC molecules and Ii. (2220758)
1990
44
Constitutive production of interleukin-6 and immunologic features in cardiac myxomas. (1690543)
1990
45
Pulmonary thromboembolism complicating recurrent placental abruption at 29 weeks' gestation. (2400355)
1990
46
Hereditary fructose intolerance. (2207353)
1990
47
The mechanism of neutropenia in Felty's syndrome. (4416356)
1974
48
Listeria meningitis in the newborn. Report of two cases and a review of the literature. (13721705)
1961
49
Changes in treatment of placenta praevia. (14833630)
1951
50

Variations for Blastomycosis

About this section

Expression for genes affiliated with Blastomycosis

About this section
Search GEO for disease gene expression data for Blastomycosis.

Pathways for genes affiliated with Blastomycosis

About this section

GO Terms for genes affiliated with Blastomycosis

About this section

Sources for Blastomycosis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet